Cemented K-wire Fixation vs Open Transfixion Pinning
Launched by THE SECOND HOSPITAL OF QINHUANGDAO · Mar 12, 2017
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Shaft fractures of the middle phalanx are common injuries that are often difficult to treat. Currently, fracture fixation is usually achieved by using K-wire, but pin configurations are controversial.The objective of this report is to introduce treatment of shaft fractures of middle phalanx with a novel external-fixation technique using combined K-wires and cement. For comparison, we also included another group of patients who were treated using open transfixion pinning.A total of 98 patients (98 fingers) with shaft fractures of middle phalanx were randomly allocated to group A (n=51) and B...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient aged between 18 and 65 years;
- • acute fractures within 15 days;
- • closed fractures or fractures with small open wound less than 1.5 cm;
- • involvement of single middle phalanges of index to little fingers;
- • shaft fractures; at least 5 mm in length of the most distal and proximal fragments so that K-wires can be secured;
- • transversal, short oblique or spiral fractures;
- • comminuted fractures of middle third phalanx;
- • normal opposite hand for comparison.
- Exclusion Criteria:
- • patients younger than 18 years are excluded because of skeletal immaturity;
- • patients older than 65 years are excluded because of possible osteoporosis;
- • multiple finger involvement; severe open injury or crush injuries;
- • combined tendon or neurovascular injuries; involvement of articular surface;
- • old fractures exceeding 15 days because close reduction most likely became difficult;
- • combined tendon, nerve, or artery injuries or diseases;
- • diabetes, gout, ganglion;
- • osseous tumors, and other disease affecting bony structures and joint motion;
- • patients who declined to participate.
About The Second Hospital Of Qinhuangdao
The Second Hospital of Qinhuangdao is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute to medical knowledge and enhance treatment modalities across various specialties, ensuring that the latest scientific advancements are translated into effective patient care. Through collaboration with healthcare professionals and researchers, the Second Hospital of Qinhuangdao strives to uphold the highest standards of ethical practice and scientific integrity in all its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, Hebei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials